Fresh Recalls

Fenofibrate Capsules: recall status

Notice names this product. Ajanta Pharma USA’s Fenofibrate Capsules is named in FDA Class II recall D-0611-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: CGMP Deviations Identifying details: Lot # PA02216; Exp. 12/2029. Units affected: 3648 bottles. Status: Ongoing.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Fenofibrate Capsules
Company / brand
Ajanta Pharma USA
Lot / serial / date codes
Lot # PA02216; Exp. 12/2029
Distribution
U.S. Nationwide
Agency product description and boundaries

Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

Brand
Ajanta Pharma USA

Recalls naming this model

FDA Class II · Drug · July 1, 2026

Fenofibrate Capsules recall — Ajanta Pharma USA Inc

CGMP Deviations

Company / brand: Ajanta Pharma USA

Affected product: Fenofibrate Capsules

Official ID D-0611-2026 · Official record ↗

See all Ajanta Pharma USA recalls →

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.